J&J to buy cardiovascular technology Abiomed in $16.6 billion deal ...Middle East

Johnson and Johnson will spend USD 16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division. The health care giant said on Tuesday that it will pay USD 380 for each Biomed share and also provide another USD 35 per share in cash if some commercial and clinical milestones are met. Abiomed develops technology that treats coronary artery disease and heart failure.

Read More Details
Finally We wish PressBee provided you with enough information of ( J&J to buy cardiovascular technology Abiomed in $16.6 billion deal )

Also on site :

• Your new sofa could be the first sign tariff inflation is hitting home
• Nvidia on AI chip bans, OpenAI gets Jony Ive, and Google's Gemini in cars: Tech news roundup
• MBZUAI eröffnet Institut für Grundlagenmodelle und gründet Silicon Valley AI Lab